The Midas Legacy Is Out To Help People Live Healthier and Protect Their Futures

The Midas Legacy is a company located in Florida that works to help people achieve their goals in life. A large number of people that come to them are entrepreneurs who are looking to find success and financial independence, which takes a lot of management skills to sustain over the long term. But this is not all, the Midas Legacy also looks to help people in other ways than just finances, such as their overall happiness and health, as the sense of self is quite important to feel successful as well. It is quite unique for a company to be concerned with all aspects of a persons life, rather than just the money aspects.

The Midas Legacy helps new entrepreneurs make proper business decisions as well as financial ones. Working through the steps and ensuring each client finds a good understanding of how to run a business means they have a higher chance at success, and it also means they will be able to help other people, through advice and jobs. Even though many of their clients are entrepreneurs, the company happily accepts any kind of client, regardless of what it is they are hoping to achieve. The Midas Legacy is always happy to work with those who want to achieve their dreams and are willing to be creative with their ideas.

They work to not only give people the answers and achieve their goals for them, but to help them learn how to motivate themselves and become more successful with their own abilities in the future. This is why all of the experts at the Midas Legacy encourage their clients to come up with their own ideas and the path that they want to take, while the company acts as a mentor to guide them.

The Midas Legacy always has the best plans in order and is ready to help people start achieving their goals today, so anyone who wants to benefit from this opportunity should take the time to see what they fully have to offer. There is no better time than today for someone to start improving their life.

Laidlaw Case Demonstrates How Everything Is Connected

On a surface level I’ve been well aware of the fact that most things in our economy are interconnected. And even more so when it comes to medical research. Academically I’m just in the periphery of things to the point where I know how drug studies are designed and implemented. But for some reason I never really considered how they’re actually funded. But all that changed when I saw a recent news story about an investment banking firm called Laidlaw. The court case is between them and a research firm called Relmada Therapeutics. However, information on the case was a bit hard to come by since part of the news involved a temporary restraining order and associated injunction against Laidlaw. I knew that if I wanted to really get a better idea of how Laidlaw and Company and similar companies worked that I’d need to investigate a bit closer to the source.

It made sense to go directly to Laidlaw’s view of things since they were the ones unable to fully represent themselves due to the court order. What I found really did shed some light on things for me. One of the most notable discoveries for me simply involved the way Laidlaw operated. I assumed that the connection between the two parties would be a fluke. Just one investment among many. But what I discovered is that Laidlaw actually has a very long history of working with medical companies. It drove home the point that Laidlaw and similar organizations are often the main reasons why medical research can occur in the first place.

But what really drove this point home was seeing the faces of some of the people at the top. I’d known the names Matthew Eitner and James Ahern from the case description. But it was very different actually seeing their faces on the site. Even more so, reading about their interests and passions. It became quite clear that they had a pattern of guiding the company to medical research. This really made me consider Laidlaw as a force for overall good. Research needs to be done, and I’d realized just how much it needs to be funded too.

Restraining Order Issued Against Laidlaw and Company

In December of 2015, the United States District Court of Nevada distributed a restraining order in addition to an injunction against Laidlaw and Company and Laidlaw’s two principal partners from publishing false and defaming materials about Relmada Therapeutics, Inc. This was done according to the court in an attempt for Laidlaw and Company to take control of the company. The court order was issued in response to Laidlaw & Company along with Eisner and Ahern’s attempt’s to take complete control of Relmada Therapeutics. In addition to the court ruling, the court also noted that Laidlaw and Company had previously served as Relmada Therapeutics investment banker and that the company’s principals, Mathew Eitner and James Ahern, have a documented reputation of disregarding U.S. financial rules and laws. All of these infractions have been brought to the attention of authorities numerous times as a consequence of multiple complaints, sanctions and financial penalties laid against Laidlaw and its principles.
This all seems to be happening because Relmada Therapeutics is a very valuable property that Laidlaw wants control of. Relmada is fundamentally a specialty pharmaceutical company that is in the process of developing for market several new versions of validated drug products. They are also in the development of a portfolio of several lead products that address untreated areas of pain management. In addition to this, the Relmada Therapeutics product development team is guided by a group of internationally recognized scientists and researchers. The incredible work and expertise of these noted men and women are expected to drastically reduce Relmada’s clinical drug development costs and their financial risks in developing these new drugs.
In addition, Relmada Therapeutics has a different product development approach. Product development is guided by an internationally recognized group of scientists and clinical researchers. This approach by the company is expected to reduce their development costs while supplying helpful products to serious medical needs. Together with the development of other singular pharmaceuticals the company has a unique set of one of a kind products in various stages of development.
Laidlaw & Company presents itself as a full-service investment banking and brokerage firm offering personal investment advice. The Principals of the firm are Mathew Eitner and James Ahern. They advertise that they offer personalized investment advice to high net worth individuals as well as private and public institutions. However, several of their brokers are under securities fraud investigations. The fraud law firm Fitapelli Kurta would like to hear from investors with complaints regarding New York-based Laidlaw broker Leonard V. Gallick, Jr. Some of the accusations against him and his firm are quite serious. This investigation coupled with the District Courts recent ruling against Laidlaw spells a less than rosy year for the firm and its partners.

Original Source: